Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 107.34
-2.38 (-2.17%)
Aug 14, 2026, 10:55 AM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.06 billion as of August 14, 2026. Its market cap has increased by 169.92% in one year.
Market Cap
1.06B
Enterprise Value
751.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
107.34
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.06B, an increase of 1,885.19%. That is a compound annual growth rate of 71.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.05B | 22.48% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 593.82M |
| Satellos Bioscience | 293.93M |
| Helix BioPharma | 126.79M |
| Eastwood Bio-Medical Canada | 96.44M |
| ME Therapeutics Holdings | 75.97M |
| MedMira | 45.61M |
| Microbix Biosystems | 44.08M |
| NurExone Biologic | 43.74M |